000 | 01224 a2200325 4500 | ||
---|---|---|---|
005 | 20250517123150.0 | ||
264 | 0 | _c20171129 | |
008 | 201711s 0 0 eng d | ||
022 | _a1365-2893 | ||
024 | 7 |
_a10.1111/jvh.12570 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aThompson, A J | |
245 | 0 | 0 |
_aVidal LL, et al. NS3 protease polymorphisms and genetic barrier to drug resistance of distinct HCV genotypes from worldwide treatment-naive subjects. JVH, 2016, 23(11): 840-849. _h[electronic resource] |
260 |
_bJournal of viral hepatitis _c11 2016 |
||
300 |
_a838-839 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aAntiviral Agents |
650 | 0 | 4 |
_aDrug Resistance _xdrug effects |
650 | 0 | 4 |
_aDrug Resistance, Viral _xdrug effects |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHepacivirus _xdrug effects |
650 | 0 | 4 | _aHepatitis C |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPeptide Hydrolases _xgenetics |
650 | 0 | 4 | _aProtease Inhibitors |
650 | 0 | 4 |
_aViral Nonstructural Proteins _xgenetics |
700 | 1 | _aBowden, D S | |
773 | 0 |
_tJournal of viral hepatitis _gvol. 23 _gno. 11 _gp. 838-839 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/jvh.12570 _zAvailable from publisher's website |
999 |
_c26569643 _d26569643 |